Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMandarin In.sg Regulatory News (MDO)

  • This share is currently suspended. It was suspended at a price of 1.65
  • There is currently no data for MDO

Company Board Changes

16 Jul 2024 10:49

RNS Number : 6025W
Mandarin Oriental International Ltd
16 July 2024
 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

 

COMPANY BOARD CHANGES

 

 

Mandarin Oriental International Limited (the 'Company') is pleased to announce the following changes to the Board:

 

Fabrice Megarbane will join the Board of the Company as an Independent Non-Executive Director with effect from 1 August 2024.

 

John Witt, Group Managing Director of Jardine Matheson, will step down as a Director from the Company's Board and as a member of the Remuneration and Nominations Committees. Adam Keswick will step down from the Nominations Committee and Graham Baker will step down from the Remuneration Committee. Adam remains as a Director. These changes will all take effect from 22 July 2024.

 

The Company is also announcing that Sean Ward will be appointed as Company Secretary, with effect from 22 July 2024, succeeding Jonathan Lloyd.

 

Fabrice Megarbane is the Chief Global Growth Officer of L'Oréal. He was previously President and CEO of L'Oréal North Asia and CEO of L'Oréal China and serves on its global executive committee. He managed a combined revenue of more than EUR10 billion, which accounts for over 25 percent of L'Oréal's global business, and an organisation of 20,000 people. Fabrice started his marketing career at L'Oréal S.A. in 2000. He brings multi-market experience, combining emerging and developed markets, including Europe, the Middle East, Africa, Germany, China and now North Asia.

 

Commenting on these changes, Chair Ben Keswick said: "I am pleased to welcome Fabrice to our Board, which will benefit from his extensive experience at L'Oréal. He is an accomplished and passionate marketer and brand builder with a deep consumer focus and extensive experience in digital transformation.

 

We will continue to enhance the composition of our Board, bringing in relevant expertise to help our management team deliver on their strategy and build long-term shareholder value.

 

I would also like to thank John and Jonathan for their service to the Board."

 

 

Jonathan Lloyd, Jardine Matheson LimitedFor and on behalf of Mandarin Oriental International Limited

 

16th July 2024

 

www.mandarinoriental.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPUBCMUPCUBQ
Date   Source Headline
2nd Mar 202310:27 amRNSAudit Committee Chairman and Membership Changes
2nd Mar 20239:30 amRNSMandarin Oriental - 2022 Preliminary Results
31st Jan 202310:49 amRNSTotal Voting Rights
10th Nov 20229:42 amRNSInterim Management Statement
26th Sep 202210:21 amRNSBlock listing Interim Review
28th Jul 202210:28 amRNSHalf Year Results
18th Jul 20225:19 pmRNSMO announces Sale of MO, Washington D.C.
19th May 202210:27 amRNSInterim Management Statement
5th May 202212:40 pmRNSResult of AGM
7th Apr 202210:35 amRNSAnnual Financial Report
31st Mar 202211:34 amRNSTotal Voting Rights
25th Mar 20229:28 amRNSBlock listing Interim Review
3rd Mar 20229:29 amRNS2021 Preliminary Announcement of Results
31st Jan 20227:18 amRNSTotal Voting Rights
31st Dec 20217:01 amRNSTotal Voting Rights
30th Nov 20219:43 amRNSTotal Voting Rights
19th Nov 20219:28 amRNSDirectorate Change
11th Nov 20219:41 amRNSInterim Management Statement
22nd Oct 202110:18 amRNSDirectorate Change
27th Sep 202110:23 amRNSBlock listing Interim Review
30th Jul 202110:20 amRNSTotal Voting Rights
29th Jul 202110:38 amRNSDirectorate Change
29th Jul 202110:23 amRNS2021 HALF YEAR FINANCIAL STATEMENTS
30th Jun 202110:21 amRNSTotal Voting Rights
1st Jun 20217:02 amRNSTotal Voting Rights
20th May 20217:00 amRNSDirectorate Change
5th May 20211:25 pmRNSResult of AGM
5th May 202110:24 amRNSInterim Management Statement
30th Apr 202110:30 amRNSTotal Voting Rights
16th Apr 202110:26 amRNSHolding(s) in Company
8th Apr 202110:31 amRNSAnnual Financial Report
25th Mar 20219:27 amRNSBlock listing Interim Review
24th Mar 20219:47 amRNSDirector Declaration
11th Mar 20219:16 amRNS2020 Preliminary Announcement of Results
3rd Dec 202012:30 pmRNSDirectorate Change
5th Nov 20209:27 amRNSInterim Management Statement
27th Oct 20209:27 amRNSDirectorate Change
27th Oct 20209:21 amRNSDirectorate Change
25th Sep 202010:50 amRNSBlock listing Interim Review
25th Sep 202010:47 amRNSDirector/PDMR Shareholding
30th Jul 202011:01 amRNSHalf-year Report
15th Jun 202010:22 amRNSDirector Declaration
29th May 202010:20 amRNSTotal Voting Rights
6th May 20201:13 pmRNSNon-Routine Resolutions submitted via NSM
6th May 20201:07 pmRNSResult of AGM
9th Apr 202010:21 amRNSInterim Management Statement
9th Apr 20207:38 amRNSAdditional Listing
7th Apr 202010:30 amRNSAnnual Financial Report
30th Mar 202011:07 amRNSDirector Declaration
25th Mar 20209:27 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.